Abbott Laboratories (ABT) – Bull of the Day
Source: http://www.zacks.com/commentary/11199/Abbott+Laboratories+%28ABT%29+-+Bull+of+the+DayPosted on Monday, June 15th, 2009 | In Market Commentary, Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
Abbott Laboratories (ABT) discovers, develops, manufactures and sells a diversified line of healthcare products. We expect almost 10% EPS growth over the next five years driven by strong sales of Humira and the company’s rapidly growing vascular business.
Several new drug applications have recently been filed with the FDA, which should accelerate sales in the pharmaceutical business. We believe ABT possesses a low risk profile and will continue to trade at an industry premium.
Accordingly, we reiterate our Buy recommendation with a price target of $65.Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- VIP Falls Behind Expectations - Analyst Blog - November 25th, 2009
- J. Crew Beats Zacks Estimates - Analyst Blog - November 25th, 2009
- No Change in Deere's Outlook - Analyst Blog - November 25th, 2009
- Sprint Acquires Virgin Mobile USA - Analyst Blog - November 25th, 2009
- Provenge Action Date Assigned - Analyst Blog - November 25th, 2009
Tags for this Post:
Abbott Laboratories, Day Abbott Laboratories;, Fda, healthcare products, Humira, Market Commentary, Pharmaceutical, Stocks to Watch, USD, Zacks Market Commentaries
Abbott Laboratories, Day Abbott Laboratories;, Fda, healthcare products, Humira, Market Commentary, Pharmaceutical, Stocks to Watch, USD, Zacks Market Commentaries
![]() About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |




